Our results provided new mechanistic insights for a better understanding of hepatotumorigenesis and revealed the functionality of the miR-202-3p/KDM3A/HOXA1/MEIS3 pathway as a potential therapeutic target for HCC. This evidence concerns the gene MEIS3 and hepatocellular carcinoma.